Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin vs Botox for Overactive Bladder Syndrome
NCT06034288Phase 2Unknown
- Sponsor
- Walter Reed National Military Medical Center
- Start
- May 2023
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in overactive bladder syndrome (OAB), sponsored by Walter Reed National Military Medical Center. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT06034288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06034288.